Mutational and haplotype analysis of AGL in patients with glycogen storage disease type III

21Citations
Citations of this article
14Readers
Mendeley users who have this article in their library.

Your institution provides access to this article.

Abstract

Glycogen storage disease type III (GSD III) is a rare autosomal recessive inherited disorder caused by a deficiency of the glycogen-debranching enzyme (AGL). We investigated two GSD III patients and identified four different mutations. Nucleotide sequence analysis revealed patient 1 of Chinese descent to be a compound heterozygote for a novel nonsense mutation, R34X, and the splicing mutation (IVS32-12A > G) reported in a Japanese patient. Patient 2 of Japanese origin was found to be compound heterozygous for a novel nonsense mutation, Y1148X, and the splicing mutation (IVS14+1G > T) that we had described previously. To determine whether splicing mutations occurred independently, we performed intense AGL haplotype analysis using 21 intragenic polymorphic markers plus a novel polymorphism IVS32-97 A/G in the vicinity of the IVS32 splicing mutation. Patient 1 of Chinese origin and the Japanese patient homozygous for the IVS32-12A > G were found to have different haplotypes, indicating the IVS32-12A > G mutation to be a recurrent mutation. This is the first recurrent mutation established by intense haplotyping in the AGL gene.

Cite

CITATION STYLE

APA

Horinishi, A., Okubo, M., Tang, N. L. S., Hui, J., To, K. F., Mabuchi, T., … Murase, T. (2002). Mutational and haplotype analysis of AGL in patients with glycogen storage disease type III. Journal of Human Genetics, 47(2), 55–59. https://doi.org/10.1007/s100380200000

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free